论文部分内容阅读
收治在我院手术治疗分化型申状腺癌２３９例，男６３例，女１７６例；首治组１５４例，再治组８５例；随访５～２０年，平均１０年零８个月，再治组与首治组的手术合并症分别为１１．８％与０．６％（Ｐ＜０．０１）。全甲状腺切除与腺叶峡部切除的手术合并症分别为２５．０％与３．０％（Ｐ＜０．０１），而次全切除则是３．３％（Ｐ＜０．０１）。腺叶峡部切除全甲状腺切除的复发率是１５．３％与０．０％（Ｐ＜０．０１），而次全切是３．８％，与全甲状腺切除相比Ｐ＜０．０５，但三者的５年，１０年生存率有明显差别。主张对分化型甲状辟癌应常规行次全切除，部分病例可选择性行全甲状腺切除。甲状腺外浸润癌仍以手术彻底切除为主，包括切除邻近的组织器官。
In our hospital, 239 cases of differentiated SG were treated in our hospital. There were 63 males and 176 females. 154 cases of the first treatment group and 85 cases of the retreatment group were followed up for 5 to 20 years with an average of 10 years and 8 months. The surgical complications in the treatment group and the first treatment group were 11.8% and 0.6%, respectively (P<0.01). The complications of total thyroidectomy and gland resection were 25.0% and 3.0%, respectively (P<0.01), while subtotal resection was 3.3% (P<0.01). The recurrence rate of total thyroidectomy for isthmectomy was 15.3% and 0.0% (P<0.01), and subtotal was 3.8%, compared with total thyroidectomy P<0.05. However, there was a significant difference in the 10-year survival rate among the three years. Advocates for differentiated thyroid cancer should be routine subtotal resection, in some cases can be selective thyroidectomy. Invasive external thyroid cancer is still mainly surgical resection, including the removal of adjacent tissues and organs.